Landscapes / Companies
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
Drugs
3
in active trials · 4 in all
Trials
8 active
9 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | Dec 2026Phase 2 trial completes | |||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Sepsis | ||||
| Open drug page | |||||
— |
Phase 2 | Jun 2027Phase 2 trial completes | |||
| Next date | Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Moderate to Severe Acute Postoperative Pain, Diabetic Peripheral Neuropathic Pain and 1 more | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Chronic Sinusitis Without Nasal Polyps | ||||
| Open drug page | |||||
About
- No active trial
- HTMC0435
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021